Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDP-choline in ATS-using adolescents
NCT02630069Phase 2Unknown
- Sponsor
- Ewha Womans University Mokdong Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of citicoline in amphetamine-type stimulant use disorder (3 arms), sponsored by Ewha Womans University Mokdong Hospital. Primary endpoints: Total number of amphetamine- and methamphetamine(MA)-negative samples at 12 weeks, Abstinence at 12 weeks and 1 more. Status: unknown.
02
Drugs
citicoline
03
Conditions
amphetamine-type stimulant use disorder
Beyond the preview
Go deeper on NCT02630069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630069.